Patents Assigned to Hummingbird Biosciences Holdings Limited
  • TREATMENT AND PREVENTION OF CANCER USING HER3 ANTIGEN-BINDING MOLECULES
    Publication number: 20220153870
    Abstract: Methods for treating or preventing a cancer in a subject are disclosed, wherein the cancer comprises cells having a mutation resulting in increased expression of a ligand for HER3, wherein the method comprises administering a therapeutically or prophylactically effective amount of an antigen-binding molecule which is capable of binding to HER3 to the subject.
    Type: Application
    Filed: November 24, 2021
    Publication date: May 19, 2022
    Applicant: Hummingbird Biosciences Holdings Limited
    Inventors: Jerome Douglas Boyd-Kirkup, Siyu Guan, Piers Ingram, Konrad Paszkiewicz, Vicente Sancenon, Dipti Thakkar, Zhihao Wu
  • Treatment and prevention of cancer using HER3 antigen-binding molecules
    Patent number: 11208498
    Abstract: Methods for treating or preventing a cancer in a subject are disclosed, wherein the cancer comprises cells having a mutation resulting in increased expression of a ligand for HER3, wherein the method comprises administering a therapeutically or prophylactically effective amount of an antigen-binding molecule which is capable of binding to HER3 to the subject.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: December 28, 2021
    Assignee: Hummingbird Bioscience Holdings Limited
    Inventors: Jerome Douglas Boyd-Kirkup, Siyu Guan, Piers Ingram, Konrad Paszkiewicz, Vicente Sancenon, Dipti Thakkar, Zhihao Wu